Cited by 253HIV Research and TreatmentT-cell and Retrovirus StudiesHIV/AIDS drug development and treatment

The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.

Defective HIV-1 proviruses produce viral proteins

Open access

Imamichi, Hiromi, Smith, Mindy, Adelsberger, Joseph W., Izumi, Taisuke, Scrimieri, Francesca, Sherman, Brad T., Rehm, Catherine A., Imamichi, Tomozumi, Pau, Alice, Catalfamo, Marta, Fauci, Anthony S., Lane, H. Clifford·2020·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.1917876117PMC PMC7035625

Open this paper in CoChat — free account

Abstract

HIV-1 proviruses persist in the CD4 + T cells of HIV-infected individuals despite years of combination antiretroviral therapy (cART) with suppression of HIV-1 RNA levels <40 copies/mL. Greater than 95% of these proviruses detected in circulating peripheral blood mononuclear cells (PBMCs) are referred to as “defective” by virtue of having large internal deletions and lethal genetic mutations. As these defective proviruses are unable to encode intact and replication-competent viruses, they have long been thought of as biologically irrelevant “graveyard” of viruses with little significance to HIV-1 pathogenesis. Contrary to this notion, we have recently demonstrated that these defective proviruses are not silent, are capable of transcribing novel unspliced forms of HIV-RNA transcripts with competent open reading frames (ORFs), and can be found in the peripheral blood CD4 + T cells of patients at all stages of HIV-1 infection. In the present study, by an approach of combining serial dilutions of CD4 + T cells and T cell–cloning technologies, we are able to demonstrate that defective proviruses that persist in HIV-infected individuals during suppressive cART are translationally competent and produce the HIV-1 Gag and Nef proteins. The HIV-RNA transcripts expressed from these defective proviruses may trigger an element of innate immunity. Likewise, the viral proteins coded in the defective proviruses may form extracellular virus-like particles and may trigger immune responses. The persistent production of HIV-1 proteins in the absence of viral replication helps explain persistent immune activation despite HIV-1 levels below detection, and also presents new challenges to HIV-1 eradication.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1073/pnas.1917876117

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
Gallo, R. C., Salahuddin, S. Z., Popovič, M., Shearer, G. M., Kaplan, M., Haynes, B. F., Palker, T. J., Redfield, R. R., Oleske, J. M., Safai, B., et al. (1984) · Science · doi:10.1126/science.6200936 · Cited by 3,639
. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
Self-citation
Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure
Ho, Y.-C., Shan, L., Hosmane, N. N., Wang, J., Laskey, S. B., Rosenbloom, D. I. S., Lai, J., Blankson, J. N., Siliciano, J. D., & Siliciano, R. F. (2013) · Cell · doi:10.1016/j.cell.2013.09.020 · Cited by 1,405
The accuracy of reverse transcriptase from HIV-1
Roberts, J. D., Bebenek, K., & Kunkel, T. A. (1988) · Science · doi:10.1126/science.2460925 · Cited by 997
Fidelity of HIV-1 reverse transcriptase
Preston, B. D., Poiesz, B. J., & Loeb, L. A. (1988) · Science · doi:10.1126/science.2460924 · Cited by 931
Defective proviruses rapidly accumulate during acute HIV-1 infection
Bruner, K. M., Murray, A. J., Pollack, R. A., Soliman, M. G., Laskey, S. B., Capoferri, A. A., Lai, J., Strain, M. C., Lada, S. M., Hoh, R., et al. (2016) · Nature Medicine · doi:10.1038/nm.4156 · Cited by 737
Molecular Characterization of Human T-Cell Leukemia (Lymphotropic) Virus Type III in the Acquired Immune Deficiency Syndrome
Shaw, G. M., Hahn, B. H., Arya, S. K., Groopman, J. E., Gallo, R. C., & Wong‐Staal, F. (1984) · Science · doi:10.1126/science.6095449 · Cited by 633
HIV-1 Reverse TranscriptionPreprint
Hu, W.-S., & Hughes, S. H. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006882 · Cited by 597
Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant
Persaud, D., Gay, H., Ziemniak, C., Chen, Y. H., Piatak, M., Chun, T., Strain, M. C., Richman, D. D., & Luzuriaga, K. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302976 · Cited by 580

Flagged first, then by citations

Show all 46 references

1 of the 46 references couldn’t be matched to a known paper.

Sorted by citations

Items 201–253 of 253

Plasmatic HIV-1 soluble gp120 is associated with immune dysfunction and inflammation in ART-treated individuals with undetectable viremiaPreprint
Benlarbi, M., Richard, J., Bourassa, C., Tolbert, W. D., Chartrand‐Lefebvre, C., Gendron‐Lepage, G., Sylla, M., Far, M. E., Messier-Peet, M., Guertin, C., et al. (2023) · medRxiv · doi:10.1101/2023.08.15.23294128 · Cited by 1
In-depth profiling of the immuno-virological landscape after a decade of sustained HIV-1 suppression following ART resumptionPreprint
Lungu, C., Hossain, T., Crespo, R., Prins, H. A. B., Hensley, K. S., Rokx, C., Rao, S., van Kampen, J. J. A., van de Vijver, D. A. M. C., Mésplède, T., et al. (2023) · medRxiv · doi:10.1101/2023.11.14.23298452 · Cited by 1
CD34-positive monocytes are highly susceptible to HIV-1Preprint
Takahashi, N., Noyori, O., Komohara, Y., Eltalkhawy, Y. M., Hirayama, M., Yoshida, R., Nakayama, H., Kuroda, M. J., Nomura, T., Ishii, H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.26.582226 · Cited by 1
Selective infection and loss of PRDM1+ LN Tfh cells in uncontrolled HIV infection precludes formation of Tfh reservoirs under ARTPreprint
Wu, V. H., Nordin, J. M. L., Pampena, M. B., Rachimi, S., Burgess, W. L., Clark, M., Robinson, J. A., Estrada, P. M. D. R., Schleimann, M. H., Torres-Ruiz, F., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.11.693731 · Cited by 1
Studies of short-term facilitation using an aplysia octopamine receptor
장덕진 (2002) · Seoul National University Open Repository (Seoul National University)
Hide and seek: for HIV-infected CD4+ T cells, playing well comes with maturity
Leyre, L., & Jones, R. B. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158872
Defective HIV DNA genomes provide ancestral relevance critical for phylogenetic inference of reservoir dynamicsPreprint
Droske, L. E., Ramirez-Mata, A. S., Cash, M. N., Estrada, J., Shank, S. D., Browning, A., Rafiei, F., Pond, S. L. K., Salemi, M., & Magalis, B. R. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.04.490630
El TARGA como factor determinante en el tamaño del reservorio y la diversidad de los genes accesorios y reguladores del provirus del VIH-1
Romero, L. L. F. (2022) · doi:10.24275/uami.bc386j502
High-Throughput Single-Cell Sequencing for Retroviral Reservoir CharacterizationPreprint
Droske, L. E., Shank, S. D., Cash, M. N., Pond, S. L. K., Salemi, M., & Magalis, B. R. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4158004
Clonally expanded HIV-1 proviruses with 5’-Leader defects can give rise to nonsuppressible residual viremia
White, J., Wu, F., Yasin, S., Moskovljevic, M., Varriale, J., Dragoni, F., Camilo-Contreras, A., Duan, J., Zheng, M., Tadzong, N. F., et al. (2023) · immuneACCESS · doi:10.21417/jaw2023jci
A detailed characterisation of drug resistance during darunavir/ritonavir (DRV/r) monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistancePreprint
Abdullahi, A., Garcı́a-Dı́az, A., Fopoussi, O. M., Beloukas, A. I., Defo, V. F., Kouanfack, C., Torimiro, J. N. E., & Geretti, A. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.15.562382
Pathogenesis of HIV-associated pain
Liu, X., & Tang, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99744-7.00035-3
HIV-1 RNA monitoring with a dual-target diagnostic assay: A case report
Sberna, G., Gagliardini, R., Rozera, G., Forbici, F., Cicalini, S., Antinori, A., Maggi, F., & Amendola, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e29842
A simple phylogenetic approach to analyze hypermutated HIV proviruses reveals insights into their dynamics and persistence during antiretroviral therapyPreprint
Shahid, A., Jones, B. R., Duncan, M. C., MacLennan, S., Dapp, M. J., Kuniholm, M. H., Aouizerat, B. E., Archin, N. M., Gange, S. J., Ofotokun, I., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4549934/v1
Human immunodeficiency virus/acquired immunodeficiency syndrome in the infant
Shetty, A. K., & Maldonado, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-79525-8.00032-9
The role of Nef in the long-term persistence of the replication-competent HIV reservoir in South African womenPreprint
Ismail, S. D., Sebaa, S., Abrahams, B., Nason, M., Mumby, M. J., Dikeakos, J. D., Joseph, S., Moeser, M., Swanstrom, R. I., Garrett, N., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.01.621615
Chronic endothelial inflammation in PWH leads to reduced circulating megakaryocyte progenitor cells
Li, T., Hadigan, C. M., Ahn, J., Mehta, C., Pierre, M. J., Mahmood, D., Özdemirli, M., James, C., Kumar, P. N., & Catálfamo, M. (2024) · Blood Vessels Thrombosis & Hemostasis · doi:10.1016/j.bvth.2024.100039
CD4 T cell counts are inversely correlated with anti-cluster A antibodies in antiretroviral therapy-treated PLWHPreprint
Benlarbi, M., Richard, J., Clemente, T., Bourassa, C., Tolbert, W. D., Gottumukkala, S., Peet, M.-M., Medjahed, H., Pazgier, M., Maldarelli, F. M., et al. (2025) · medRxiv · doi:10.1101/2025.02.25.25322882
HIV-specific CD8+ T-cell responses soon after treatment initiation during acute HIV infection are associated with viral reservoir declinePreprint
van Paassen, P. M., Pasternak, A. O., van Dort, K. A., van Nuenen, A. C., Maurer, I., Boeser‐Nunnink, B., Buchholtz, N. V., Mahmoudi, T., Lungu, C., van Crevel, R., et al. (2025) · eLife · doi:10.7554/elife.106402.1
Identification of polymorphisms associated with attenuation of Vif and Vpr in HIV-1 Elite Controllers
de Azevedo, S. S. D., Côrtes, F. H., Morgado, M. G., Hoagland, B., Villela, L. M., Grinsztejn, B. G. J., Veloso, V. G., & Bello, G. (2025) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760240274
t-RNA mediates provirus deletion in HIV-infected cells
Gurgo, C., & Franchini, G. (2025) · Retrovirology · doi:10.1186/s12977-025-00667-0
MARMARA ÜNİVERSİTESİ PENDİK EĞİTİM VE ARAŞTIRMA HASTANESİ’NDE TAKİP EDİLEN HIV İLE YAŞAYAN BİREYLERİN KEMİK MİNERAL YOĞUNLUKLARININ DEĞERLENDİRİLMESİ
Şengel, B. E., Yılmaztürk, E. N., Buz-Yalug, B., Tigen, E. T., Çağlayık, D. Y., Sili, U., & Korten, V. (2025) · ANKEM Dergisi · doi:10.54962/ankemderg.1737161
Selective persistence of HIV-1-infected T cell clones can occur through immune reprogramming driven by defective, transcriptionally active provirusesPreprint
Hamann, M. V., Brauckmann, L., Schwarz, C., Spohn, M., Stoeck, R., Leddy, S. M., Frouard, J., Adiba, M., Winzer, R., Virdi, S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.22.676989
WITHDRAWN: Defective HIV DNA genomes provide ancestralrelevance critical for phylogenetic inference of reservoir dynamicsPreprint
Droske, L. E., Ramirez-Mata, A. S., Cash, M. N., Estrada, J., Shank, S. D., Browning, A., Rafiei, F., Pond, S. L. K., Salemi, M., & Magalis, B. R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.03.680205
HIV-specific CD8+ T-cell proliferative response 24 weeks after early antiretroviral therapy initiation predicts the subsequent reduction of the viral reservoirPreprint
van Paassen, P. M., Pasternak, A. O., Bolluyt, D. C., van Dort, K. A., van Nuenen, A. C., Maurer, I., Boeser‐Nunnink, B., Buchholtz, N. V., Mahmoudi, T., Lungu, C., et al. (2025) · eLife · doi:10.7554/elife.106402.2
Additional file 1 of Sustained gut dysbiosis and intestinal inflammation show correlation with weight gain in person with chronic HIV infection on antiretroviral therapy
Ishizaka, A., Koga, M., Mizutani, T., Suzuki, Y., Matano, T., & Yotsuyanagi, H. (2024) · Figshare · doi:10.6084/m9.figshare.26753023
An immunofluorescence microscopy assay to discriminate distinct expression patterns of HIV-1 Gag and Nef proteins in HIV-1 provirus-harboring cells
Wiscovitch-Russo, R., Sui, H., Smith, M., Imamichi, H., Lane, H. C., & Imamichi, T. (2026) · PLoS ONE · doi:10.1371/journal.pone.0340463
Self-citation
Immortalization and Targeted Enrichment of HIV-Infected CD4+ T-Cells from Patients Under Antiretroviral Therapy
Bruchey, W., Paudel, S., McCormack, A. L., Imamichi, T., & Laverdure, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27021086
Self-citation
The effect of combining HIV latency reversal with inhibition of phosphoinositide-3 kinases or B-cell lymphoma-2 on the HIV reservoir
Kim, Y., Anderson, J. L., Tumpach, C., Solomon, A. E., Ong, J., Tanaka, K., Zerbato, J. M., Tan, T., Teh, C. E., Gray, D. H. D., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1013923
Molecular factors associated with lung cancer in people living with HIV
Bautista-Rojas, I. D., Figueroa-Navarrete, J., Reyes-Hernandez, D. L., & Rivera-Toledo, E. (2026) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2026.105791
The HIV reservoir landscape in elite controllers
Moral-Turón, C., Antequera-Martínez, M., & Ruíz-Mateos, E. (2026) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000001026 · Cited by 1
High-throughput high content quantification of HIV-1 viral infectious output
LuPone, T., Brantly, A., Oteju, O., Matt, S. M., Runner, K., Nickoloff-Bybel, E. A., Nonnemacher, M. R., & Gaskill, P. J. (2026) · PLoS ONE · doi:10.1371/journal.pone.0328121
Undetectable unintegrated HIV-DNA in persons with HIV: frequency and determinants
Orlandi, C., Canovari, B., Barchiesi, F., Magnani, M., Rocchi, M. B. L., Maria, A. D., & Casabianca, A. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13113-z
Factors that contribute to B cell oncogenesis in people living with HIV
Shmakova, A. (2023) · theses.fr (ABES) · doi:10.70675/1d51b9d6z9a12z41f9z8f98z0c7f955aeb54
Is the molecular microenvironment of the latent HIV reservoir predictable using deep learning approaches?
Chen, H. (2026) · Journal of Virology · doi:10.1128/jvi.00175-26
Salivary protein profile of PLHIV on long-term antiretroviral therapy suggests latent reservoir and immune exhaustion
MACEDO, N. F., BAGGIO, G. L., de Oliveira, J. C., Buccio, I. P., da Silva, N. D. G., Ventura, T. M. O., Carvalho, T. S., Souza, P. H. C., Rosa, E. A. R., Lima, A. D. P., et al. (2026) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2026.106624
Early intervention, lasting impact: benefits of early antiretroviral therapy and implications for posttreatment control
Bolluyt, D. C., de Bree, G. J., & Pasternak, A. O. (2026) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000001040
HIV-1 virome profiling using HIV-PULSE to guide therapeutic and curative interventions
Braekeleer, S. D., Lambrechts, L., Termote, L., Delporte, M., Mehta, K., Matzaraki, V., Blomme, E. E., Lemey, P., Vrancken, B., Rokx, C., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106297
Persistent Microglial HIV Infection Drives Neuroinflammation Despite Viral Suppression: Insights from Rapid Postmortem Brain BiopsiesPreprint
Nühn, M. M., Sabet, N., Zuidmeer, N., van Abeelen, K. C. J., Hermans, L. E., Schipper, P. J., Kübler, R., Basson, A. E., Omar, T., Variava, E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.20.726582 · Cited by 1
Identification of distinct HIV reservoir phenotypes and associated immune landscapes
Wang, R., Bhattacharyya, A. B., Pohlenz, L., Shirk, E. N., Romero, H., Haas, K., Coughlin, J. M., Dastgheyb, R. M., Rubin, L. H., & Veenhuis, R. T. (2026) · JCI Insight · doi:10.1172/jci.insight.203765
Positioning HIV SMRTcap within the HIV reservoir toolbox
Loddo, A., Delobel, P., & Vellas, C. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014257
Enhanced strand transfer and mismatch extension by HIV-1C reverse transcriptase promote sequence motif duplication
Panchapakesan, A., Joshi, A. P., Amanullah, A., Pargain, N., Mehta, K., Shanmugam, M., Singh, J., Saini, C., Nala, N., Ramagopal, U. A., et al. (2026) · Journal of Virology · doi:10.1128/jvi.00526-26
5′ leader defects drive persistent HIV-1 viremia on long-term ART
Box, J. R., Camilo-Contreras, A., Dragoni, F., Yue, F. Y., Matveev, V., Foley, J., Zhang, J., Mok, Y. W., DeSousa, M., Lai, J., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73475-5
New horizons in HIV neuropathogenesis: thinking beyond the brain
Angelovich, T. A., Busman‐Sahay, K., Eddine, J. J., Churchill, M. J., Okoye, A. A., & Estes, J. D. (2026) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000001052
Genomic landscape of HIV-1 proviruses in ART-treated immunological non-responders
Tang, S., Wang, Y., Lu, Y., Tong, Z., Guo, J., Cui, Y., Harypursat, V., Chen, Y., Ouyang, J., Li, H., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1804632
Residual HIV activity and host immunometabolic remodeling during antiretroviral therapy: implications for cardiovascular–kidney–metabolic risk
Zhang, J., Li, X., Chen, C., Wu, Z., Qin, F., Li, Y., Zhang, Y., & Ning, C. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1912904
Persistent Microglial HIV Infection Drives Neuroinflammation Despite Viral Suppression: Insights from Rapid Postmortem Brain BiopsiesPreprint
Nühn, M. M., Sabet, N., Zuidmeer, N., van Abeelen, K. C. J., Hermans, L. E., Schipper, P. J., Kübler, R., Adriaan, E. B., Omar, T., Variava, E., et al. (2026) · eLife · doi:10.7554/elife.111801
Persistent Microglial HIV Infection Drives Neuroinflammation Despite Viral Suppression: Insights from Rapid Postmortem Brain BiopsiesPreprint
Nühn, M. M., Sabet, N., Zuidmeer, N., van Abeelen, K. C. J., Hermans, L. E., Schipper, P. J., Kübler, R., Adriaan, E. B., Omar, T., Variava, E., et al. (2026) · eLife · doi:10.7554/elife.111801.1
Central Nervous System Reservoirs and HIV Cure: Therapeutic Opportunities and Challenges
Angelovich, T. A., Roche, M., Gorry, P. R., & Churchill, M. J. (2026) · Current HIV/AIDS Reports · doi:10.1007/s11904-026-00798-9
mGem: Innate immune sensing of HIV-1 transcription in myeloid cells—a tale of two transcription start sites
Hughes, I. A., & Gummuluru, S. (2026) · mBio · doi:10.1128/mbio.03340-25
Selective persistence of HIV-1-infected T cell clones can occur through immune reprogramming driven by defective, transcriptionally active proviruses
Hamann, M. V., Brauckmann, L., Schwarz, C., Spohn, M., Stoeck, R., Leddy, S. M., Frouard, J., Adiba, M., Winzer, R., Hausmann, F., et al. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014618
Systemic lupus erythematosus and related autoimmune manifestations in people living with HIV-1 in the antiretroviral therapy era: phenotypes, mechanisms and clinical implications
Nakazibwe, A., Babirye, S., Okema, J. N., Githinji, R. N., Mburugu, G. W., Mudenyo, R. M., Kitololo, M. M., Kamara, L. N., Bochaberi, I. O., Maiyo, K. K., et al. (2026) · F1000Research · doi:10.12688/f1000research.192469.1
Clinical and immunological correlates of CXCR4 coreceptor use in people with HIV-1 receiving antiretroviral therapy in the Netherlands: a multicentre cohort study
Mehta, K., Otten, T., Rios-Vazquez, V., Delporte, M., Verschoore, M., Blomme, E. E., Rokx, C., Stalenhoef, J. E., Berrevoets, M. A. H., van Lunzen, J., et al. (2026) · The Lancet Microbe · doi:10.1016/j.lanmic.2026.101518

Authors: Imamichi, H., Smith, M., Adelsberger, J. W., Izumi, T., Scrimieri, F., Sherman, B. T., Rehm, C. A., Imamichi, T., Pau, A., Catalfamo, M., Fauci, A. S., & Lane, H. C.
Affiliations: National Institutes of Health (US)
Frederick National Laboratory for Cancer Research (US)
Department of Microbiology and Immunology, Georgetown University School of Medicine, Washington, DC 20057
Corresponding author: Fauci, Anthony S.
Lane, H. Clifford
ORCID: Imamichi, Hiromi
Izumi, Taisuke
Sherman, Brad T.
Rehm, Catherine A.
Imamichi, Tomozumi
Pau, Alice
Fauci, Anthony S.
Lane, H. Clifford
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 2020-02-06
Volume: 117
Issue: 7
Pages: 3704-3710
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.1917876117
PMC: PMC7035625
OpenAlex: W3005267901
Cited by: 251
References: 46
Citations by year: 2026: 38 · 2025: 41 · 2024: 40 · 2023: 41 · 2022: 33 · 2021: 38 · 2020: 19
FWCI: 17.40
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by-nc-nd
creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
Locations: Proceedings of the National Academy of Sciences (publishedVersion, cc-by-nc-nd)
PubMed Central (publishedVersion, cc-by-nc-nd)
PubMed (publishedVersion)
Funders: Division of Intramural Research, National Institute of Allergy and Infectious Diseases (N/A)
Topics: Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords: HIV-1 Gag protein, HIV-1 Nef, CD4+ T cells, highly active antiretroviral therapy, viral persistence, open reading frames, virus-like particles, innate immunity, persistent immune activation, HIV-1 eradication
MeSH terms: Humans, Leukocytes, Mononuclear, Male, Middle Aged, Proviruses, Viral Proteins, CD4-Positive T-Lymphocytes, HIV-1, HIV Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Defective HIV-1 proviruses produce viral proteins

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks